Resolution of in flammation: state of the art, definitions and terms
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
A recent focus meeting on Controlling Acute Inflammation was held in London, April 27–28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society. We concluded at the meeting that a consensus report was needed that addresses the rapid progress in this emerging field and details how the specific study of resolution of acute inflammation provides leads for novel anti‐inflammatory therapeutics, as well as defines the terms and key components of interest in the resolution process within tissues as appreciated today. The inflammatory response protects the body against infection and injury but can itself become dysregulated with deleterious consequences to the host. It is now evident that endogenous biochemical pathways activated during defense reactions can counter‐regulate inflammation and promote resolution. Hence, resolution is an active rather than a passive process, as once believed, which now promises novel approaches for the treatment of inflammation‐associated diseases based on endogenous agonists of resolution.—Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., Wallace, J. L. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325–332 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The process of inflammation resolution involves not only passive mechanisms, e.g., dissipation of chemotactic gradient or initial danger signals, but also active biochemical pathways [103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 3×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
Background(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 2×
“1C), may lead to prolonged inflammation and the inability for the tissue to return to homeostasis (26) and complete the full life-cycle per se of the neutrophils and mononuclear cells recruited to the tissue.”
BackgroundSelf-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · cited 1×
“Nalp3 occurs in an inflammasome complex with caspase-1, ASC, cardinal, and Nalp2 ( 12 ).”
BackgroundMolecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684 · cited 1×
“Uric acid is the causative agent of gout but is also released by damaged cells, possibly as a general signal for inflammation (15).”
BackgroundSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 1×
“Additionally, the widely used aspirin jump-starts resolution by making up for its loss in prostaglandin production, which plays key roles in resolution, by instead generating the epimeric version of lipid mediators (25), such as the aspirin-triggered lipoxins (recently reviewed in ref.”
BackgroundSelf-citationNegative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 8×
“In effect, TLRs sow the seeds of their own destruction, and the role of negative regulators clearly indicates how robust the TLR system is.”
BackgroundInfluentialSelf-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“enzymes are expressed (31), and whether it is resolving”
BackgroundSelf-citationRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401 · cited 4×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
BackgroundInfluentialInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Self-citation
Cited by
Items 601–700 of 1,000
Mastromarino, M., Lacivita, E., Colabufo, N. A., & Leopoldo, M. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200719014433 · Cited by 29
Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro
Salas-Hernández, A. V., Espinoza-Pérez, C., Vivar, R., Espitia-Corredor, J., Lillo, J., Parra-Flores, P., Sánchez‐Ferrer, C. F., Peiró, C., & Díaz-Araya, G. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06133-8 · Cited by 29
Nerve Growth Factor Regulates Neurolymphatic Remodeling during Corneal Inflammation and Resolution
Fink, D. M., Connor, A. L., Kelley, P. M., Steele, M. M., Hollingsworth, M. A., & Tempero, R. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112737 · Cited by 26
Zarić, S., Coulter, W. A., Shelburne, C. E., Fulton, C. R., Zaric, M., Scott, A., Lappin, M. J., Fitzgerald, D. C., Irwin, C. R., & Taggart, C. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.252791 · Cited by 29
Lipoxygenase-Derived Arachidonic Acid Metabolites in Chronic Obstructive Pulmonary Disease
Balode, L., Strazda, G., Jurka, N., Kopeika, U., Kislina, A., Bukovskis, M., Beinare, M., Gardjušina, V., & Taivāns, I. (2011) · Medicina · doi:10.3390/medicina48060043 · Cited by 29
Mechanisms underlying heterologous skin scaffold-mediated tissue remodeling
Mimura, K. K. O., Moraes, A. R., Miranda, A. C., Greco, R., Ansari, T., Sibbons, P. D., Greco, K. V., & Oliani, S. M. (2016) · Scientific Reports · doi:10.1038/srep35074 · Cited by 28
van der Windt, G. J. W., Hoogendijk, A. J., de Vos, A. F., Kerver, M., Florquin, S., & van der Poll, T. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.206 · Cited by 26
“9 The host response to bacterial pneumonia can be roughly divided in an acute response, seeking to kill the pathogens that try to invade the lower airways, and a late response, with the primary aim to clear the inflammatory reaction and restore tissue homeostasis”
BackgroundPanzer, U., Zahner, G., Wienberg, U., Steinmetz, O. M., Peters, A., Turner, J., Paust, H., Wolf, G., Stahl, R. A. K., & Schneider, A. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn361 · Cited by 26
“However, the mechanisms that are important for an attenuation of the proinflammatory mediators—and thus potentially for a switch from the inflammatory process toward ‘resolution’ or healing—are less well characterized [19,20].”
Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis
Hong, T.-T., Huang, J., Barrett, T. D., & Lucchesi, B. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00646.2007 · Cited by 25
“Acute inflammatory reactions, in contrast to chronic inflammatory reactions, are usually self-limiting and undergo resolution, which is reported to be dependent on COX-2 (14, 19, 37, 41, 54).”
BackgroundDeng, T., Feng, X., Liu, P., Yan, K., Chen, Y., & Han, D. (2013) · Immunology & Cell Biology · doi:10.1038/icb.2012.45 · Cited by 25
5α‐Reduced glucocorticoids exhibit dissociated anti‐inflammatory and metabolic effects
Yang, C., Nixon, M., Kenyon, C. J., Livingstone, D., Duffin, R., Rossi, A., Walker, B., & Andrew, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01465.x · Cited by 34
“The suppressive effects of glucocorticoids on TNF-a and IL-6 are exerted through GR-protein interactions, including NFkB and AP-1 (Smoak and Cidlowski, 2004; Serhan et al., 2007), while glucocorticoid transactivates IL-10 expression through GR interaction with STAT3 (Unterberger et al.”
BackgroundInfluentialSelf-citationWu, D., Zheng, S., Li, W., Yang, L., Liu, Y., Zheng, X., Yang, Y., Yang, L.-M., Wang, Q., Smith, F. G., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/964012 · Cited by 28
“However, fibroblasts are known to play a specific role in inflammation resolution after an acute injury [9].”
BackgroundDavies, C. L., Patir, A., & McColl, B. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01048 · Cited by 26
“An important conceptual principle to emerge that underpins how inflammation is brought under control outside the brain is that it involves active induction of pro-resolution cellular and molecular processes and is not simply the waning of the initial inflammatory response (63).”
BackgroundSpecialized pro-resolving mediators in diabetes: novel therapeutic strategies
Brennan, E. P., Mohan, M., Andrews, D. C., Bose, M., & Kantharidis, P. (2019) · Clinical Science · doi:10.1042/cs20190067 · Cited by 30
Jordan, P. M., Goethem, E. V., Müller, A. M., Hemmer, K., Gavioli, V., Baillif, V., Burmeister, Y., Krömmelbein, N., Dubourdeau, M., Seilheimer, B., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14111123 · Cited by 32
“In this respect, SPMs as novel immunoresolvents have been investigated in numerous experimental studies and showed promising therapeutic potential for treatment of inflammatory diseases [6,7,18,31].”
BackgroundTanwar, V. S., Reddy, M. A., Das, S., Samara, V. A., Abdollahi, M., Dey, S., Malek, V., Ganguly, R., Stapleton, K., Lanting, L. L., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318536 · Cited by 27
Persistent Unresolved Inflammation in theMecp2-308 Female Mutated Mouse Model of Rett Syndrome
Cortelazzo, A., Felice, C. D., Filippis, B. D., Ricceri, L., Laviola, G., Leoncini, S., Signorini, C., Pescaglini, M., Guerranti, R., Timperio, A. M., et al. (2017) · Mediators of Inflammation · doi:10.1155/2017/9467819 · Cited by 27
“Thus, the cellular mechanisms by which resolution occurs and the key biochemical pathways associated with the return to homeostasis/catabasis (return from disease) clearly open many new avenues for potential therapeutic interventions in a wide range of diseases associated with unresolved inflammation [57].”
BackgroundMarteyn, B., Burgel, P., Meijer, L., & Witko‐Sarsat, V. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00243 · Cited by 29
“An alternative approach for the development of novel therapeutics is now based on endogenous mechanisms that switch off acute inflammation and bring about its resolution (Serhan et al., 2007).”
The Inhibition of Phosphoinositide-3 Kinases Induce Resolution of Inflammation in a Gout Model
Galvão, I., Queiroz‐Junior, C. M., de Oliveira, V. L. S., Pinho, V., Hirsch, E., & Teixeira, M. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01505 · Cited by 31
Ma, Q., Zhang, Z., Shim, J., Venkatraman, T. N., Lascola, C. D., Quiñones, Q. J., Mathew, J. P., Terrando, N., & Podgoreanu, M. V. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00608 · Cited by 28
“Resolvins act to block neutrophil and monocyte migration and reduce the oxidative burst of neutrophils (Serhan et al., 2007; Perretti et al., 2015).”
BackgroundPentraxin 3 deficiency exacerbates lipopolysaccharide-induced inflammation in adipose tissue
Guo, H., Qiu, X., Deis, J. A., Lin, T., & Chen, X. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0402-4 · Cited by 29
Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
Recchiuti, A., Isopi, E., Romano, M., & Mattoscio, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186637 · Cited by 27
“In addition to efferocytosis, MΦs are also able to remove the inflammatory trigger by non-phlogistic phagocytosis [47].”
BackgroundHart, S. P., Rossi, A. G., Haslett, C., & Dransfield, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033142 · Cited by 24
“ment of inflammatory diseases requires an understanding the cellular and molecular mechanisms underlying development and progression of inflammation [1].”
BackgroundSelf-citationChemokine neutralization as an innovative therapeutic strategy for atopic dermatitis
Abboud, D., & Hanson, J. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.023 · Cited by 24
Innate Immune Pathways in Atherosclerosis—From Signaling to Long-Term Epigenetic Reprogramming
Aronova, A., Tosato, F., Naser, N., & Asare, Y. (2023) · Cells · doi:10.3390/cells12192359 · Cited by 26
“Later, mononuclear cells, including lymphocytes and monocytes/macrophages, accumulate to aid in tissue resolution and repair [22].”
BackgroundAnti‐Inflammatory Potential of Chalcone Related Compounds: An Updated Review
Yadav, A., Sharma, V., & Singh, G. (2024) · ChemistrySelect · doi:10.1002/slct.202401321 · Cited by 32
MiR‐146b Mediates Endotoxin Tolerance in Human Phagocytes
Renzi, T. A., Rubino, M., Gornati, L., Garlanda, C., Locati, M., & Curtale, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/145305 · Cited by 37
The role of the lipidome in obesity-mediated colon cancer risk
Jain, R., Pickens, C. A., & Fenton, J. I. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.015 · Cited by 26
Skin well-being in diabetes: Role of macrophages
Yaseen, H., & Khamaisi, M. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104154 · Cited by 26
15-Deoxy-△12,14-Prostaglandin J2 Promotes Resolution of Experimentally Induced Colitis
Kim, W., Jang, J., Zhong, X., Seo, H., & Surh, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.615803 · Cited by 33
“After its completion of critical function in host defense, acute inflammation should be properly resolved to avoid chronic inflammation responsible for the pathogenesis of many prevalent disorders, such as cancer, obesity, and IBD (38).”
BackgroundTargeting macrophages in the tumour environment to enhance the efficacy of αOX40 therapy
Gough, M. J., Killeen, N. P., & Weinberg, A. D. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03600.x · Cited by 24
New pathways to control inflammatory responses in adipose tissue
Akasheh, R. T., Pang, J., York, J. M., & Fantuzzi, G. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.04.008 · Cited by 26
“Mediators in this category can be targeted by novel, agonist strategies that offer the likelihood of less severe side-effects compared to the standard anti-inflammatory approaches currently employed [4].”
BackgroundAmaral, M. B. F., de Freitas, J. B., & Mesquita, R. A. (2012) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2012.04.016 · Cited by 24
Effects of Tithonia diversifolia (Asteraceae) extract on innate inflammatory responses
Broering, M. F., Nunes, R., Faveri, R. D., Faveri, A. D., Melato, J., Corrêa, T. P., Vieira, M. E., Malheiros, Â., Quintão, N. L. M., & Santin, J. R. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112041 · Cited by 26
Mariqueo, T. A., & Zúñiga‐Hernández, J. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102095 · Cited by 24
Crocetti, L., Vergelli, C., Cilibrizzi, A., Graziano, A., Khlebnikov, А. I., Kirpotina, L. N., Schepetkin, I. A., Quinn, M. T., & Giovannoni, M. P. (2013) · Drug Development Research · doi:10.1002/ddr.21076 · Cited by 24
“Likewise, FPRs may represent therapeutic targets for selectively stimulating innate immune responses [Serhan et al., 2007; Zhang and Falla, 2009; Dufton and Perretti, 2010].”
BackgroundNeutrophils secrete exosome-associated DNA to resolve sterile acute inflammation
Arya, S. B., Collie, S. P., Xu, Y., Fernandez, M., Sexton, J. Z., Mosalaganti, S., Coulombe, P. A., & Parent, C. A. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01671-4 · Cited by 26
Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease
Spite, M. R. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003030 · Cited by 25
“Key checkpoints in the resolution of inflammation include the termination of PMN infiltration into the injured tissue, the timely apoptosis of PMN, active clearance of apoptotic PMN, microbes and other dead tissue by macrophages, and the efflux of phagocytes from the injured area((41,42)).”
BackgroundLipoxin A 4 promotes lung epithelial repair whilst inhibiting fibroblast proliferation
Zheng, S., D’Souza, V., Bartis, D., Dancer, R. C. A., Parekh, D., Naidu, B. V., Smith, F. G., Wang, Q., Jin, S., Lian, Q., et al. (2016) · ERJ Open Research · doi:10.1183/23120541.00079-2015 · Cited by 23
Pathophysiology and clinical relevance of atrial myopathy
Tubeeckx, M., Keulenaer, G. W. D., Heidbüchel, H., & Segers, V. F. M. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01038-0 · Cited by 30
“[57, 75, 219, 259, 260] Defective reversal of the inflammatory cascade can lead to chronic inflammation, which is proarrhythmic [75].”
Molecular Circuits of Resolution in the Eye
Liclican, E. L., & Gronert, K. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.99 · Cited by 22
“An impressive body of work has demonstrated that these endogenous lipid circuits are integral components of an acute inflammatory response, which is dependent on the balanced activation of pro- and anti-inflammatory circuits, controlled wound healing, and active resolution of leukocytes[42,50,98,99,100,101].”
BackgroundMeerarani, P., Krishnan, P., Purushothaman, K., Baber, U., Tarricone, A. N., Pérez, J. S., Wiley, J. M., Kini, A. S., Sharma, S. K., Fuster, V., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.252122 · Cited by 25
“This study also documented significant downregulation of anti-inflammatory mediator IL-10 gene and protein, an important molecule in the resolution of inflammation.(36,37) Lower serum IL-10 levels are linked to acute coronary syndromes increasing future atherothrombotic events.”
BackgroundHolen, E., He, J., Espe, M., Chen, L., & Araujo, P. W. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.05.017 · Cited by 23
Pharmacological regulation of neutrophil activity and apoptosis
Jančinová, V., Perečko, T., Nosáľ, R., Mihalová, D., Bauerová, K., & Drábiková, K. (2011) · Interdisciplinary Toxicology · doi:10.2478/v10102-011-0003-0 · Cited by 24
Dynamic transcriptome analysis unveils key proresolving factors of chronic inflammatory arthritis
Kong, J., Park, J.-H., Yoo, S., Kim, K.-M., Bae, Y.-J., Park, Y., Cho, C., Hwang, D., & Kim, W. (2020) · Journal of Clinical Investigation · doi:10.1172/jci126866 · Cited by 26
“Together with previous reports (3, 16, 22, 23), our data suggest that the upregulated 37 hub-like molecules may serve as a comprehensive resource for potential proresolving factors.”
BackgroundResultNeutrophil–Endothelial Cell Interactions
Filep, J. G., & Colgan, S. P. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9781139195737.013 · Cited by 24
Agrawal, N. (2025) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70114 · Cited by 22
Susceptibility Factors in Chronic Lung Inflammatory Responses to Engineered Nanomaterials
You, D. J., & Bonner, J. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197310 · Cited by 26
Campos‐Sánchez, J. C., Mayor-Lafuente, J., Guardiola, F. A., & Esteban, M. Á. (2021) · Fish Physiology and Biochemistry · doi:10.1007/s10695-021-00999-6 · Cited by 22
“However, if these mechanisms fail to restore homeostasis, inflammation may persist, resulting in a pathological state of chronic inflammation and even chronic diseases (Nathan and Ding 2010; Serhan et al. 2011).”
BackgroundGobbetti, T., Faouder, P. L., Bertrand‐Michel, J., Dubourdeau, M., Barocelli, E., Cénac, N., & Vergnolle, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075581 · Cited by 22
“phase and a return to homeostasis [2].”
Decreased activity and accelerated apoptosis of neutrophils in the presence of natural polyphenols
Jančinová, V., Perečko, T., Harmatha, J., Nosáľ, R., & Drábiková, K. (2012) · Interdisciplinary Toxicology · doi:10.2478/v10102-012-0010-9 · Cited by 22
Anti-inflammatory effect of rosuvastatin decreases alveolar bone loss in experimental periodontitis
Kırzıoğlu, F. Y., Bulut, M. T., Doğan, B., Fentoğlu, Ö., Özmen, Ö., Çarsancaklı, S. A., Ergün, A. G., Özdem, M., & Orhan, H. (2017) · Journal of Oral Science · doi:10.2334/josnusd.16-0398 · Cited by 22
“Although rosuvastatin decreases oxidative stress, its anti-inflammatory effects appear to be more remarkable than amelioration of oxidative status, perhaps through agonistic resolution of inflammation via receptor-mediated cellular signals, rather than through antagonistic mechanisms (57).”
BackgroundSong, J., Jung, K. J., Yang, M., Han, S.-C., & Lee, K. (2020) · Toxicological Research · doi:10.1007/s43188-020-00058-x · Cited by 24
Doskey, C. M., Fader, K. A., Nault, R., Lydic, T. A., Matthews, J. B., Potter, D., Sharratt, B., Williams, K. J., & Zacharewski, T. R. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115034 · Cited by 25
“Resolvins (Rv) D1 and D2 are potent anti-inflammatory and pro-resolving lipid mediators arising from ω-3 PUFAs (i.e. DHA and EPA) (Serhan et al., 2007a; Serhan, 2007b).”
BackgroundThe Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review
de Fáveri, C., Fermino, P. M. P., Piovezan, A. P., & Volpato, L. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094370 · Cited by 23
“The resolution of inflammation is an active process where the activation of endogenous factors allows the host tissue to maintain homeostasis [11].”
BackgroundResolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases
Hiram, R. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07230-6 · Cited by 24
Nguyen, H. T., Thi, T. H. N., Braire, J., Thi, T. A. D., & Van, T. N. (2023) · ChemistrySelect · doi:10.1002/slct.202204376 · Cited by 21
Macrophage mediators and mechanisms in cardiovascular disease
Schelemei, P., Wagner, E., Picard, F. S. R., & Winkels, H. (2024) · The FASEB Journal · doi:10.1096/fj.202302001r · Cited by 23
Common Therapeutic Targets in Cardiometabolic Disease
Fredman, G., Özcan, L., & Tabas, I. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008908 · Cited by 24
Coupling inflammation with evo-devo
Aller, M., Arias, N., Fuentes‐Julián, S., Blázquez-Martínez, A., Argudo, S., de Miguel, M.-P., Arias, J.-L., & Arias, J. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.02.018 · Cited by 22
“Obviously, the mechanisms that promote tissue structure and restoring of functions also include the mechanisms involved in the resolution of inflammation [94].”
BackgroundMetabolism of Anandamide into Eoxamides by 15‐Lipoxygenase‐1 and Glutathione Transferases
Forsell, P. K. A. L., Brunnström, Å., Johannesson, M., & Claesson, H. (2012) · Lipids · doi:10.1007/s11745-012-3684-z · Cited by 21
“On the other hand, 15-LO-1 metabolites have also been demonstrated to possess anti-inflammatory roles [14].”
BackgroundKimura, L. F., Prezotto-Neto, J. P., Távora, B. D. C. L. F., Faquim-Mauro, E. L., Pereira, N. A., Antoniazzi, M. M., Jared, S. G. S., Teixeira, C., Santoro, M. L., & Barbaro, K. C. (2015) · Toxicon · doi:10.1016/j.toxicon.2015.06.006 · Cited by 23
“Inflammation is a complex and multimediated process related to host defense, which is accompanied by the production and release of several inflammatory mediators (Serhan et al., 2007).”
BackgroundAnnexin A1, FPR2/ALX, and inflammatory cytokine expression in peritoneal endometriosis
Volpato, L. K., Horewicz, V. V., Bobinski, F., Martins, D. F., & Piovezan, A. P. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.08.002 · Cited by 23
Sordi, R., Bet, Â. C., Justina, A. M. D., Ramos, G. C., & Assreuy, J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173095 · Cited by 23
Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis
Rodríguez‐Carrio, J., Coras, R., Alpéri, M., López, P., Ulloa, C., Ballina‐García, F. J., Armando, A. M., Quehenberger, O., Gumá, M., & Suárez, A. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41537 · Cited by 22
“However, antiinflammatory and proresolving functions are not equivalent (38), and it is plausible that a stronger shift toward proresolution may be needed to control the phase of CSA transitioning to RA.”
BackgroundOptimal combination of anti-inflammatory components from Chinese medicinal formula Liang-Ge-San
Lu, Z., Cao, H., Liu, D., Zheng, Y., Tian, C., Liu, S., Quan, J., Shi, L., Liu, J., & Yu, L. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113747 · Cited by 21
Resolution of cell-mediated airways diseases
Persson, C. G. A., & Uller, L. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-75 · Cited by 25
“In vitro studies on steroid-induced apoptosis of dendritic cells are scarce whereas steroid-induced apoptosis of eosinophils and lymphocytes [1,29,30] has received much attention.”
BackgroundInfluentialChávez‐Piña, A. E., Vong, L., McKnight, W., Dicay, M. S., Zanardo, R. C. O., Ortiz, M. I., Castañeda‐Hernández, G., & Wallace, J. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.316 · Cited by 21
“Although aspirininduced acetylation of COX-2 results in inhibition of PG synthesis, arachidonic acid can still be metabolized to 15-Rhydroxyeicosatetraenoic acid, and then further metabolized (through 5-lipoxygenase) to produce 15-R-epi-lipoxin A4 (Serhan et al., 2007).”
BackgroundSelf-citationChistyakov, D. V., Nikolskaya, A. I., Goriainov, S. V., Astakhova, A. A., & Sergeeva, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218203 · Cited by 21
“It is known that, besides the release of pro- and anti-inflammatory cytokines, cellular responses to inflammatory stimuli are characterized by oxylipins synthesis [37].”
BackgroundProgesterone differentially affects the transcriptomic profiles of cow endometrial cell types
Pereira, G., Guo, Y., Silva, E., Bevilacqua, C., Charpigny, G., Lopes-da-Costa, L., & Humblot, P. (2022) · BMC Genomics · doi:10.1186/s12864-022-08323-z · Cited by 24
“Annexin A1 is a pro-resolving mediator involved in the clearance of apoptotic cells [74, 75].”
BackgroundResolution pharmacology and the treatment of infectious diseases
Costa, V. V., Resende, F., Melo, E. M., & Teixeira, M. M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16323 · Cited by 21
“…on lipid mediators in inflammatory exudates and inflamed tissues during inflammation onset and resolution were first to identify a series of novel pro-resolving molecules that drive the major cellular events of inflammation resolution (reviewed by Serhan et al., 2007; Sugimoto et al., 2016, 2019).”
BackgroundContributions of neutrophils to resolution of mucosal inflammation
Colgan, S. P., Ehrentraut, S., Glover, L. E., Kominsky, D. J., & Campbell, E. L. (2012) · Immunologic Research · doi:10.1007/s12026-012-8350-2 · Cited by 22
“Of particular interest are series of LM termed resolvins (Rv) and maresins (MaR) [3, 5, 65].”
BackgroundHu, W., van Steijn, L., Li, C., Verbeek, F. J., Cao, L., Merks, R. M. H., & Spaink, H. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.624571 · Cited by 27
Zhao, T., Ma, D., Mulati, A., Zhao, B., Liu, F., & Liu, X. (2021) · Food & Function · doi:10.1039/d0fo03018j · Cited by 21
Khlebnikov, А. I., Schepetkin, I. A., Kirpotina, L. N., Brive, L., Dahlgren, C., Jutila, M. A., & Quinn, M. T. (2011) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1307-x · Cited by 22
Myeloid Cells in Cutaneous Wound Repair
Cash, J. L., & Martin, P. B. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0017-2015 · Cited by 24
Oliveira, L. G., Testasicca, M. C. D. S., Vago, J. P., Figueiredo, A. B., Canavaci, A. M. C., Perucci, L. O., Ferreira, T. P. T., Coelho, E. A. F., Gonçalves, D. U., Rocha, M. O. D. C., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602028 · Cited by 20
Clemente‐Napimoga, J. T., Silva, M. A. S. M., Peres, S. N. C., Lopes, A. H., Lóssio, C. F., Oliveira, M. V., Osterne, V. J. S., Nascimento, K. S., Abdalla, H. B., Teixeira, J. M., et al. (2018) · Biochimie · doi:10.1016/j.biochi.2018.12.007 · Cited by 20
Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock
Sordi, R., Chiazza, F., Collotta, D., Migliaretti, G., Colas, R. A., Vulliamy, P., Brohi, K., Dalli, J., Collino, M., & Thiemermann, C. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003407 · Cited by 22
“Resolvin D1 (RvD1), a bioactive lipid mediator synthesized from docosahexaenoic acid, is member of the resolvin family that mediates resolution of inflammation.(22,23) RvD1 reduces the inflammation and lung injury caused by lipopolysaccharide(24); it reduces the inflammation in endometriosis(25) and improves survival…”
BackgroundParashar, K., Schulte, F., Hardt, M., & Baker, O. J. (2020) · The FASEB Journal · doi:10.1096/fj.201902196r · Cited by 22
The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
Sousa, A. B., & Barbosa, J. N. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14040223 · Cited by 23
The utilisation of resolvins in medicine and tissue engineering
Blaudez, F., Ivanovski, S., Fournier, B., & Vaquette, C. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.11.047 · Cited by 19
Altemus, J. B., Dadgar, N., Li, Y., & Lightner, A. L. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30756 · Cited by 19
“…resolution has been considered a passive operation; unique molecular and cellular mechanisms involved in inflammation resolution have been identified in which macrophages play an important role in preventing excessive immune responses (Chen et al., 2018; Serhan et al., 2007; Sugimoto et al., 2016).”
BackgroundThe Multifaceted Role of Annexin A1 in Viral Infections
Resende, F., de Araújo, S., Tavares, L. P., Teixeira, M. M., & Costa, V. V. (2023) · Cells · doi:10.3390/cells12081131 · Cited by 23
Liu, L., Yao, Y., Liu, Y., Hong, B., Li, Z., Chen, X., Zhang, Y., Fu, H., Yang, D., & Yang, C. (2024) · Biomaterials Research · doi:10.34133/bmr.0061 · Cited by 21
“The above results showed that RAPA/ JK-1-PLGA@PM possessed favorable inhibitory myocardial injury and inflammatory properties, owing to significant anti-apoptosis and attenuation effects of pro-inflammatory factors by H 2 S [10,41].”
ResultRegulation of immune cell signaling by activated protein C
Healy, L. D., Rigg, R. A., Griffin, J. H., & McCarty, O. J. T. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0817-338r · Cited by 22
The role of netrin-1 in the mouse cornea during Aspergillus fumigatus infection
Zhou, Y., Lin, J., Peng, X., Li, C., Zhang, J., Wang, Q., Zhu, G., You, J., & Zhao, G. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.03.047 · Cited by 20
Melanocortin Control of Cell Trafficking in Vascular Inflammation
Patel, H., Leoni, G., Montero‐Melendez, T., Sampaio, A. L. F., & Perretti, M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6354-3_7 · Cited by 19
Self-citationResolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease
Anand, S., Ansari, M. A., Sukrutha, S. K., Alomary, M. N., Khan, A. A., & Elderdery, A. Y. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.001 · Cited by 17
Cholinergic macrophages promote the resolution of peritoneal inflammation
Luo, S., Lin, H., Wu, C., Zhu, L., Hua, Q., Weng, Y., Wang, L., Fan, X., Zhao, K.-B., Liu, G., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402143121 · Cited by 22
Bascuñán, K. A., Araya, M., Rodríguez, J. M., Roncoroni, L., Elli, L., Alvarez, J. D. P. L., & Valenzuela, R. (2025) · Nutrients · doi:10.3390/nu17040621 · Cited by 21
“In inflammatory bowel diseases (IBDs), such as ulcerative colitis and Crohn’s disease, doses between 1000 and 3000 mg per day of EPA and DHA have been shown to have beneficial anti-inflammatory effects [103].”
ResolvinD1 reduces apoptosis and inflammation in primary human alveolar epithelial type 2 cells
Xie, W., Wang, H., Liu, Q., Li, Y., Wang, J., Yao, S., & Wu, Q. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.31 · Cited by 18
Carneiro, N. V. Q., SILVA, H. B. F. D., da Silva, R. R., CARNEIRO, T. C. B., Costa, R. D. S., Pires, A. O., Marques, C. R., Velozo, E. S., Conceição, A. D. S., Silva, T. M. S., et al. (2019) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201920170831 · Cited by 19
Sequential Wnt Agonist Then Antagonist Treatment Accelerates Tissue Repair and Minimizes Fibrosis
Tian, X., Zhou, D. F., Fu, H., Zhang, R., Wang, X., Huang, S., Liu, Y., & Xing, J. (2020) · iScience · doi:10.1016/j.isci.2020.101047 · Cited by 22
Mediators and receptors in the resolution of inflammation: drug targeting opportunities
Stewart, A. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00484.x · Cited by 20
“It does highlight the increasingly recognized need to evaluate new agents for their impact on inflammation-resolving mechanisms (Serhan et al., 2007), a potential referred to as ‘resolution-toxic’ (Perretti and Dalli, 2009).”
BackgroundFaraj, A. A., Shaik, A. S., & Alnafea, M. A. (2015) · BMC Medical Imaging · doi:10.1186/s12880-015-0059-y · Cited by 20
“and coordinated processes orchestrated by AM [3, 4].”
Resolution of leucocyte‐mediated mucosal diseases. A novel in vivo paradigm for drug development
Persson, C. G. A., & Uller, L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01772.x · Cited by 18
“Increasing the interest further, glucocorticoids are thought to exert both these actions (Serhan et al., 2007; Perretti and D’Acquisto, 2009).”
BackgroundThe essential role of annexin A1 mimetic peptide in the skin allograft survival
Teixeira, R. A. P., Mimura, K. K. O., Araújo, L. P., Greco, K. V., & Oliani, S. M. (2013) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1773 · Cited by 18
“Also, by promoting phagocytosis of apoptotic neutrophils, and restoring the pre-inflammatory state of the tissue or organ (Serhan et al., 2007).”
BackgroundCharacterization of Toxicological Properties of L-Lysine Polymers in CD-1 Mice
Titlow, W. B., Lee, C.-H., & Ryou, C. (2013) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1302.02055 · Cited by 20
“The increase of granulocyte differential is suggestive of an inflammatory process that may be associated with chemical poisoning and other toxic states [22], but the validity of this phenomenon is obscure because it was an isolated case resulting from the acute test and this was not repeated in the subchronic test.”
BackgroundInterleukin-17A negatively regulates lymphangiogenesis in T helper 17 cell-mediated inflammation
Park, H. J., Yuk, C. M., Shin, K., & Lee, S.-H. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.76 · Cited by 18
Metadata
- Authors
- Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L.
- Affiliations
- Brigham and Women's Hospital (US)
- King's College London (GB)
- University of Birmingham (GB)
- University College London (GB)
- Centre for Inflammation Research (GB)
- Trinity College Dublin (IE)
- Queen Mary University of London (GB)
- University of Calgary (CA)
- Corresponding author
- Serhan, Charles N.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-02
- Volume
- 21
- Issue
- 2
- Pages
- 325-332
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3119634
- OpenAlex
- W2120699390
- Cited by
- 1,045
- References
- 36
- Citations by year
- 2026: 20 · 2025: 26 · 2024: 30 · 2023: 46 · 2022: 42 · 2021: 59 · 2020: 70 · 2019: 53 · 2018: 57 · 2017: 59 · 2016: 57 · 2015: 66 · 2014: 65 · 2013: 90 · 2012: 74
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Norges Idrettshøgskole
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- inflammation resolution, acute inflammation, anti-inflammatory agents, inflammation-associated diseases
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Leukocytes, Models, Biological, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.